Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: A double blind randomized clinical trial.
Evaluation of Study and Patient Characteristics of Clinical Studies in Primary Progressive Multiple Sclerosis: A Systematic Review.
Neural Plasticity in Multiple Sclerosis: The Functional and Molecular Background.
New Data Show Longer Tysabri Dosing Interval in MS Is Feasible
Quantitative MRI for Analysis of Active Multiple Sclerosis Lesions without Gadolinium-Based Contrast Agent.
Lipid domains control myelin basic protein adsorption and membrane interactions between model myelin lipid bilayers.
Transverse Myelitis Associated With an Itchy Rash and HyperCkemia: Neuromyelitis Optica Associated With Dermatitis Herpetiformis.
Clinical experience of natalizumab in Crohn's disease patients in a restricted distribution program.
No association between CCL2 gene polymorphisms and risk of inflammatory demyelinating diseases in a Korean population.
Teva Presents New Clinical Safety Data in RRMS Patients Treated with Laquinimod for Two or More Years at Joint ACTRIMS-ECTRIMS Meeting
Latin American algorithm for treatment of relapsing-remitting multiple sclerosis using disease-modifying agents.
Frequent early multiple sclerosis relapses during treatment with fingolimod: a paradoxical effect?
Spinocerebellar Ataxias Type 8, 12, and 17 and Dentatorubro-Pallidoluysian Atrophy in Czech Ataxic Patients.
Cognition and eye movements: assessment of cerebral dysfunction.
Longitudinal changes in self-reported walking ability in multiple sclerosis.
Promotion and prevention of autoimmune disease by CD8+ T cells.
Multiple sclerosis presenting initially with a worsening of migraine symptoms.
Analyzing differences between patient and proxy on Patient Reported Outcomes in multiple sclerosis.
Does jcv antibody positivity encourage cessation of natalizumab therapy in multiple sclerosis?
Effects of exercise training on fatigue in multiple sclerosis: a meta-analysis.
The multiple sclerosis drug fingolimod (FTY720) stimulates neuronal gene expression, axonal growth and regeneration.
Statins: From cholesterol-lowering drugs to novel immunomodulators for the treatment of Th17-mediated autoimmune diseases.
Serum lactate as a novel potential biomarker in multiple sclerosis.
Quantitative texture analysis of brain white matter lesions derived from T2-weighted MR images in MS patients with clinically isolated syndrome.
Common mechanisms in neurodegeneration and neuroinflammation: a BrainNet Europe gene expression microarray study.

Pages